CASC3 and Miyoshi myopathy: This clear correlation between metabolic rewiring and BTZ resistance in the MM TME encourages further studies to determine the causal mechanism and further metabolic effects, which will benefit novel therapeutic paradigms, ultimately improving the treatment of relapsed MM.